Everolimus-Eluting Platinum Chromium Coronary Stent System
Leading on Studying Short DAPT
Boston Scientific is committed to clinical science that meets what physicians encounter in their everyday practice, including the need for shortened DAPT. We are studying shortened DAPT with the SYNERGY Bioabsorbable Polymer (BP) Stent in various patient populations.
SYNERGY BP-DES was intentionally designed to enable short DAPT.
6-month DAPT in ACS elderly patients
View the SENIOR Trial data
SYNERGY BP-DES vs REBEL™ BMS
EVOLVE Short DAPT
3-month DAPT in HBR patients
IDE Trial | SYNERGY BP-DES
IDEAL Left Main*
12-month DAPT in Left Main with Xience™ PP-DES
Left Main PCI